Amaxa® Nucleofector® Technology is a highly efficient non-viral method for transfection. It is based on 2 components: the Nucleofector® Device that delivers unique electrical parameters, and Nucleofector® Kits. These contain Lonza certified cuvettes, pipettes, Nucleofector® Solution and Supplement. Each solution and supplement is individually developed for every primary cell type. For cell lines, five different Nucleofector® Solutions (C, L, R, T and V) are available. The electrical parameters of the Nucleofector® Device are different from any other commercially available electroporation device. Each electrical setting is displayed as a distinct program which has been adapted to the requirements of a particular cell type. As the electrical settings are pre-programmed into the Nucleofector® Device, optimization of the electrical parameters by the user is not necessary.
If your search on our database results in an equipment or facilities collaboration we'd like to hear about it, all feedback on both successes and challenges will help us in enabling more partnerships. Click on the feedback tab.